About this Medicine article
Biogen and Samsung Bioepis Announce European Launch of IMRALDITM(adalimumab), Solidifying Leadership in European Anti-TNF Market is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- Oxford University Press; Oxford University Press (OUP) (ISSN 1462-0324)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)